Literature DB >> 11849798

CT findings at the primary site of oropharyngeal squamous cell carcinoma within 6-8 weeks after definitive radiotherapy as predictors of primary site control.

Hiroya Ojiri1, William M Mendenhall, Anthony A Mancuso.   

Abstract

PURPOSE: To determine whether findings on CT studies, done 6 weeks after radiotherapy (RT), can predict the likelihood of ultimate control at the primary site in oropharyngeal carcinoma. METHODS AND MATERIALS: Forty-six patients with oropharyngeal squamous cell carcinoma underwent RT with curative intent. A minimal 2-year clinical follow-up after RT was required. The primary site CT findings were graded for risk of recurrence on a modified 3-point scale as follows: Grade 0, no detectable focal abnormalities; Grade 1, anatomic asymmetry or focal mass <1 cm; Grade 2, focal mass >10 mm (2a) or <50% shrinkage of the mass as seen on pretreatment studies (2b).
RESULTS: No patients with CT findings of Grade 0 (n = 26) or Grade 1 (n = 5) had a primary site recurrence. One of the 13 patients with CT findings of Grade 2a had a primary site recurrence 1 year after completion of RT. None of the 2 patients with CT findings of Grade 2b had a primary site recurrence. Ultimately, 45 of the 46 patients in this study group had disease control at the primary site.
CONCLUSION: In the evaluation of oropharyngeal squamous cell carcinoma on post-RT CT studies, diffuse and symmetric post-RT changes of the soft tissue or asymmetry without detectable mass or a discrete mass < or =10 mm always indicated ultimate control at the primary site. Even when post-RT CT shows a discrete mass >10 mm at the primary site, the likelihood of local control is high (93%). The study results indicate that CT findings, based on this relatively small series, may not add incremental information beyond that of clinical examination for predicting local control but may be useful as a baseline if imaging surveillance is contemplated.

Entities:  

Mesh:

Year:  2002        PMID: 11849798     DOI: 10.1016/s0360-3016(01)02671-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

Review 1.  Assessment of treatment response after chemoradiation of head and neck cancer.

Authors:  Fernando Luiz Dias
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

2.  Response evaluation after chemoradiotherapy for advanced staged oropharyngeal squamous cell carcinoma: a nationwide survey in the Netherlands.

Authors:  Charlotte S Schouten; Otto S Hoekstra; C René Leemans; Jonas A Castelijns; Remco de Bree
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-06       Impact factor: 2.503

3.  Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck.

Authors:  Daniel A Hamstra; Kuei C Lee; Bradford A Moffat; Thomas L Chenevert; Alnawaz Rehemtulla; Brian D Ross
Journal:  Transl Oncol       Date:  2008-12       Impact factor: 4.243

4.  Pre- and post-radiotherapy MRI results as a predictive model for response in laryngeal carcinoma.

Authors:  Redina Ljumanovic; Johannes A Langendijk; Otto S Hoekstra; Dirk L Knol; C René Leemans; Jonas A Castelijns
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

5.  T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma.

Authors:  A D King; C K Keung; K-H Yu; F K F Mo; K S Bhatia; D K W Yeung; G M K Tse; A C Vlantis; A T Ahuja
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-10       Impact factor: 3.825

6.  Tumor Regression Patterns Based on Follow-up Duration in Patients With Head and Neck Squamous Cell Carcinoma Treated With Radiotherapy or Chemoradiotherapy.

Authors:  Moonkyoo Kong; Seong Eon Hong
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-11-10       Impact factor: 3.372

7.  Value of Dynamic Contrast-Enhanced MRI to Detect Local Tumor Recurrence in Primary Head and Neck Cancer Patients.

Authors:  Young Jun Choi; Jeong Hyun Lee; Yu Sub Sung; Ra Gyoung Yoon; Ji Eun Park; Soon Yuhl Nam; Jung Hwan Baek
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

8.  A predictive model for residual disease after (chemo) radiotherapy in oropharyngeal carcinoma: Combined radiological and clinical evaluation of tumor response.

Authors:  Zeno A R Gouw; Bas Jasperse; Jan-Jakob Sonke; Wilma D Heemsbergen; Arash Navran; Olga Hamming-Vrieze; Jan Paul de Boer; Michiel W M van den Brekel; Abrahim Al-Mamgani
Journal:  Clin Transl Radiat Oncol       Date:  2017-08-04

9.  MRI in head and neck cancer following chemoradiotherapy: what is the optimal delay to demonstrate maximal response?

Authors:  S E J Connor; C Burd; N Sivarasan; V Goh
Journal:  Eur Radiol       Date:  2021-05-19       Impact factor: 5.315

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.